Major depressive disorder Trials in Albuquerque, United States
Conditions / Major depressive disorder / Albuquerque, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
42 total trials for this combination
Showing top 10 of 42 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01715805 | Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT01838876 | Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01457677 | ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment | COMPLETED | PHASE2 |
| NCT06898879 | Enhancing Veteran-Clinical Collaboration in VA PRRCs | NOT_YET_RECRUITING | — |
| NCT01156415 | Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT00467402 | Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06029439 | Study to Assess the Safety and Effectiveness of NMRA-335140-501 | RECRUITING | PHASE3 |
| NCT02141399 | A Long-Term Safety Study of ALKS 5461 | COMPLETED | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |